Physician profile
James Bruno
NPI 1780673244
$8,763.58
in general payments reported to CMS, 2019-2025
21 companies · $927 in 2025
The $927 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,313 · 2020: $1,721 · 2021: $1,900 · 2022: $680 · 2023: $723 · 2024: $499 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,975 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,974.50 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,171.26 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Insmed, INC. | $1,672.78 | 2019-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $1,181.44 | 2019-2024 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $761.92 | 2019-2021 | |
| Philips North America LLC | $760.49 | 2019-2022 | |
| Genentech USA, INC. | $696.52 | 2019-2022 | |
| Glaxosmithkline, LLC. | $652.70 | 2019-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $234.89 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $180.92 | 2021-2022 | |
| Allergan, INC. | $124.77 | 2020 | |
| Optinose US, INC. | $69.43 | 2021 | |
| Merck Sharp & Dohme LLC | $59.39 | 2019-2023 | |
| Advanced Respiratory, INC | $41.35 | 2020 | |
| Mallinckrodt Enterprises LLC | $26.13 | 2019 | |
| United Therapeutics Corporation | $21.32 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $19.72 | 2019 | |
| Acorda Therapeutics, INC | $19.20 | 2021 | |
| Agiliti Surgical, INC. | $18.75 | 2024 | Sonablate Hifu, Koelis Trinity Fusion Biopsy System |
| Mylan Specialty L.P. | $18.58 | 2019 | |
| Mallinckrodt Hospital Products INC. | $17.19 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.